Marc Deloger

18PUBLICATIONS
239CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 08, 2025
DC subsets and states unraveled across human juxtatumoral and malignant tissues.

Kevin Mulder, Margaux Gardet, Wan Ting Kong

|Jul 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers.

Roman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki

|Jun 13, 2024
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.

Javier Carmona, Elena Chavarria, Kate Donoghue

|Dec 05, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.

Susanne A Gatz, Anne C Harttrampf, Caroline Brard

|Jul 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.

Fernanda Mosele, Elise Deluche, Amelie Lusque

|Mar 02, 2023
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer.

Yoann Pradat, Julien Viot, Andrey A Yurchenko

Pageof 3

Frequent Collaborators

5 joint publications

Nathalie Droin

4 joint publications

Laurence Zitvogel

3 joint publications

Carlos de la Calle-Fabregat

3 joint publications

Guilhem Pupier